|
2025-06-10 |
2025-06-10 |
PS
Planned sale
|
Nichols Christian Todd
SVP, Chief Commercial Officer
Officer
|
3,334
-3.7%
31.09
USD 103,654
|
3,334
-3.7%
|
31.09
|
USD 103,654
|
|
|
2025-06-10 |
2025-06-09 |
PS
Planned sale
|
Nichols Christian Todd
SVP, Chief Commercial Officer
Officer
|
3,333
-3.6%
31.95
USD 106,489
|
3,333
-3.6%
|
31.95
|
USD 106,489
|
|
|
2025-02-28 |
2025-02-28 |
PS
Planned sale
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Officer
|
1,938
-20.1%
34.00
USD 65,892
|
1,938
-20.1%
|
34.00
|
USD 65,892
|
|
|
2025-02-25 |
2025-02-25 |
PS
Planned sale
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Officer
|
3,743
-32.7%
35.26
USD 131,978
|
3,743
-32.7%
|
35.26
|
USD 131,978
|
|
|
2025-02-20 |
2025-02-20 |
PS
Planned sale
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Officer
|
1,327
-14.7%
35.69
USD 47,361
|
1,327
-14.7%
|
35.69
|
USD 47,361
|
|
|
2025-02-14 |
2025-02-13 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
108,833
-65.3%
36.02
USD 3,920,001
|
108,833
-65.3%
|
36.02
|
USD 3,920,001
|
|
|
2025-02-14 |
2025-02-13 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
35,586
-17.6%
34.02
USD 1,210,696
|
35,586
-17.6%
|
34.02
|
USD 1,210,696
|
|
|
2025-02-14 |
2025-02-12 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
33,108
-36.4%
33.27
USD 1,101,470
|
33,108
-36.4%
|
33.27
|
USD 1,101,470
|
|
|
2025-02-14 |
2025-02-12 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
171,813
-65.4%
32.69
USD 5,616,808
|
171,813
-65.4%
|
32.69
|
USD 5,616,808
|
|
|
2025-01-31 |
2025-01-30 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
100,918
-69.5%
32.05
USD 3,234,382
|
100,918
-69.5%
|
32.05
|
USD 3,234,382
|
|
|
2024-12-09 |
2024-12-09 |
PS
Planned sale
|
LAURENCIN CATO T
Non-Executive Director
|
2,691
-10.5%
31.85
USD 85,708
|
2,691
-10.5%
|
31.85
|
USD 85,708
|
|
|
2024-12-09 |
2024-12-09 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
61,151
-56.2%
32.07
USD 1,961,406
|
61,151
-56.2%
|
32.07
|
USD 1,961,406
|
|
|
2024-12-05 |
2024-12-05 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
9,221
-13.4%
31.50
USD 290,462
|
9,221
-13.4%
|
31.50
|
USD 290,462
|
|
|
2024-12-04 |
2024-12-04 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
14,349
-17.2%
30.77
USD 441,550
|
14,349
-17.2%
|
30.77
|
USD 441,550
|
|
|
2024-11-27 |
2024-11-27 |
PS
Planned sale
|
Nichols Christian Todd
SVP, Chief Commercial Officer
Officer
|
5,208
-7.9%
29.15
USD 151,813
|
5,208
-7.9%
|
29.15
|
USD 151,813
|
|
|
2024-11-12 |
2024-11-11 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
58,996
-41.5%
30.08
USD 1,774,576
|
58,996
-41.5%
|
30.08
|
USD 1,774,576
|
|
|
2024-11-06 |
2024-11-06 |
PS
Planned sale
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Officer
|
10,471
-9.5%
29.53
USD 309,169
|
10,471
-9.5%
|
29.53
|
USD 309,169
|
|
|
2024-03-18 |
2024-03-18 |
PS
Planned sale
|
Nichols Christian Todd
SVP, Chief Commercial Officer
Officer
|
10,417
-13.6%
28.10
USD 292,740
|
10,417
-13.6%
|
28.10
|
USD 292,740
|
|
|
2024-02-27 |
2024-02-27 |
S
Sale
|
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Officer
|
2,559
-24.9%
29.65
USD 75,874
|
2,559
-24.9%
|
29.65
|
USD 75,874
|
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
LAURENCIN CATO T
Non-Executive Director
|
2,690
-15.1%
31.85
USD 85,677
|
2,690
-15.1%
|
31.85
|
USD 85,677
|
|
